Curcumin reverses the sunitinib resistance in clear cell renal cell carcinoma (ccRCC) through the induction of ferroptosis via the ADAMTS18 gene
Authors:
Open Access
- 1 July 2021
- journal article
- research article
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 10 (7) , 3158-3167
Abstract
Curcumin reverses the sunitinib resistance in clear cell renal cell carcinoma (ccRCC) through the induction of ferroptosis via the ADAMTS18 gene Ben Xu, Wei-Jie Zhu, Yi-Ji Peng, Si-Da ChengKeywords
This publication has 22 references indexed in Scilit:
- Current Challenges in Diagnosis and Assessment of the Response of Locally Advanced and Metastatic Renal Cell CarcinomaRadioGraphics, 2019
- Growth and Proliferation of Renal Cell Carcinoma Cells Is Blocked by Low Curcumin Concentrations Combined with Visible Light IrradiationInternational Journal of Molecular Sciences, 2019
- Therapeutic Targeting of Sunitinib-Induced AR Phosphorylation in Renal Cell CarcinomaCancer Research, 2018
- Unraveling the Anticancer Effect of Curcumin and ResveratrolNutrients, 2016
- Fibroblast Growth Factor Receptor-Dependent and -Independent Paracrine Signaling by Sunitinib-Resistant Renal Cell CarcinomaMolecular and Cellular Biology, 2016
- NCOA1 promotes angiogenesis in breast tumors by simultaneously enhancing both HIF1α- and AP-1-mediated VEGFa transcriptionOncotarget, 2015
- The Multifaceted Role of Curcumin in Cancer Prevention and TreatmentMolecules, 2015
- Hypermethylation of the 16q23.1 Tumor Suppressor Gene ADAMTS18 in Clear Cell Renal Cell CarcinomaInternational Journal of Molecular Sciences, 2015
- Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagyNature, 2014
- The Molecular Basis for the Pharmacokinetics and Pharmacodynamics of Curcumin and Its Metabolites in Relation to CancerPharmacological Reviews, 2014